Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ponce, PR
NPI
1104018654
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1006 Parra Medical Institute 2225 Ponce by Pass, Suite 1006
Ponce, PR, 00717
Phone (787) 840-8686
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
339 services
Medicare patients, 2024
110
Average age 77
Drug cost, 2024
$3.3M
33,210 prescriptions
Company payments, 2025
$193
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cesar H Trabanco was code 99214 (office e&m - established), 147 times for 83 patients. In total Cesar H Trabanco billed 339 services in 8 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 147 | 83 | $81.43 | $12K |
| 99213 Office E&M - Established | Office | 49 | 35 | $46.66 | $2,286 |
By year: 2022 $27K for 389 services; 2023 $23K for 326 services; 2024 $24K for 339 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cesar H Trabanco prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 5,287 prescriptions and refills. In total Cesar H Trabanco wrote 33,210 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 5,287 | 6,949 | 894 | $328K |
| Atorvastatin Calcium Generic | 1,648 | 2,409 | 392 | $13K |
| Rosuvastatin Calcium Generic | 1,239 | 1,872 | 301 | $11K |
| Simvastatin Generic | 1,123 | 1,534 | 227 | $6,796 |
| Gabapentin Generic | 1,107 | 1,474 | 229 | $11K |
| Losartan Potassium Generic | 974 | 1,433 | 231 | $7,878 |
| Metformin Hcl Generic | 957 | 1,377 | 209 | $5,944 |
| Levothyroxine Sodium Generic | 740 | 1,077 | 153 | $7,887 |
| Amlodipine Besylate Generic | 671 | 1,006 | 170 | $3,461 |
| Janumet Sitagliptin Phos/Metformin Hcl | 659 | 792 | 115 | $449K |
| Glimepiride Generic | 613 | 900 | 123 | $6,736 |
| Metoprolol Succinate Generic | 554 | 814 | 134 | $6,863 |
| Synjardy Empagliflozin/Metformin Hcl | 519 | 553 | 104 | $332K |
| Carvedilol Generic | 462 | 631 | 117 | $3,377 |
| Omeprazole Generic | 447 | 566 | 91 | $2,996 |
Brand drugs: 11,200 claims; generic drugs: 21,357 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cesar H Trabanco $193 ($193 in general payments such as food, travel and fees) from 3 companies. The largest payer was Madrigal Pharmaceuticals with $148.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.